Alkermes plc (ALKS) Estados Financieros e Histórico

Alkermes plc (ALKS) — Precio $46.07 HealthcareDrug Manufacturers - Specialty & Generic — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Alkermes plc (ALKS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Alkermes plc registró ingresos de $1.48B en el último ejercicio fiscal, con un CAGR de 5 años del 7.3%.

Márgenes de los últimos 12 meses: margen bruto 84.6%, margen operativo 7.0%, margen neto 4.0%. El flujo de caja libre creció a un CAGR del 63.9% en 5 años.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$745.7M$903.4M$1.09B$1.17B$1.04B$1.17B$1.11B$1.66B$1.56B$1.48B
Coste de Ventas$132.1M$154.7M$176.4M$180.4M$178.3M$197.3M$218.1M$253.0M$245.3M$196.5M
Beneficio Bruto$613.6M$748.6M$917.9M$990.6M$860.4M$976.4M$893.7M$1.41B$1.31B$1.28B
I+D$387.1M$412.9M$425.4M$512.8M$394.6M$290.9M$272.7M$270.8M$245.3M$324.0M
Generales y Administrativos$374.1M$421.6M$526.4M$599.4M$538.8M$549.6M$590.8M$689.8M$645.2M$714.5M
Gastos Operativos$822.2M$896.5M$1.02B$1.17B$972.9M$878.7M$899.8M$996.2M$891.7M$1.03B
Beneficio Operativo-$208.7M-$147.9M-$99.1M-$175.5M-$112.4M$97.7M-$6.1M$414.1M$420.6M$254.0M
EBITDA-$105.2M-$32.7M-$7.9M-$103.0M-$6.0M$177.6M$59.8M$519.5M$494.9M$330.9M
Gastos por Intereses$14.9M$12.0M$15.4M$13.6M$8.7M$11.2M$13.0M$23.0M$22.6M$12.3M
Beneficio Antes de Impuestos-$214.4M-$143.3M-$127.0M-$197.1M-$96.5M$87.7M-$31.1M$421.5M$443.8M$291.4M
Impuestos-$5.9M$14.7M$12.3M-$436000$14.3M$11.3M$2.0M-$97.6M$71.6M$49.8M
Beneficio Neto-$208.4M-$157.9M-$139.3M-$196.6M-$110.9M-$48.2M-$158.3M$355.8M$367.1M$241.7M
BPA$-1.38$-1.03$-0.90$-1.25$-0.70$-0.30$-0.97$2.14$2.22$1.47
BPA Diluido$-1.38$-1.03$-0.90$-1.25$-0.70$-0.30$-0.97$2.10$2.17$1.43
Acciones en Circulación (Diluidas)$151.5M$153.4M$155.1M$157.1M$158.8M$160.9M$163.7M$169.7M$169.2M$168.7M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$394.2M$384.5M$392.9M$496.0M
Beneficio Bruto$342.6M$338.3M$331.3M$397.9M
Beneficio Operativo$89.1M$58.1M-$48.3M$18.4M
EBITDA$108.8M$76.5M-$21.6M$54.3M
Beneficio Neto$82.8M$49.3M-$66.5M$501000
BPA$0.50$0.30$-0.40$0.00
BPA Diluido$0.49$0.29$-0.40$0.00

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$186.4M$191.3M$266.8M$203.8M$273.0M$337.5M$292.5M$457.5M$291.1M$1.12B
Inversiones a Corto$310.9M$242.2M$272.5M$331.2M$362.1M$198.8M$316.0M$316.0M$460.5M$199.6M
Cuentas por Cobrar$191.1M$233.6M$300.5M$265.5M$289.5M$326.6M$296.9M$333.2M$389.5M$334.0M
Inventario$63.0M$93.3M$90.2M$101.8M$125.7M$150.3M$181.4M$186.4M$182.9M$196.6M
Activos Corrientes$912.6M$966.1M$983.3M$962.0M$1.11B$1.06B$1.13B$1.49B$1.42B$1.93B
Inmovilizado Material$264.8M$284.7M$310.0M$374.5M$481.7M$456.7M$320.5M$318.4M$311.8M$298.9M
Fondo de Comercio$92.9M$92.9M$92.9M$92.9M$92.9M$92.9M$83.0M$83.0M$83.0M0
Activos Intangibles$318.2M$256.2M$191.0M$150.6M$111.2M$74.0M$37.7M$2.0M$890000$83.8M
Activos Totales$1.73B$1.80B$1.83B$1.81B$1.95B$2.02B$1.96B$2.14B$2.06B$2.53B
Cuentas por Pagar$46.3M$55.5M$39.8M$54.3M$46.0M$55.7M$32.8M$65.6M$45.6M$108.0M
Deuda a Corto$3.0M$3.0M$2.8M$2.8M$2.8M$3.0M$3.0M$3.0M0$6.7M
Pasivos Corrientes$212.0M$291.1M$339.8M$391.1M$438.3M$471.3M$497.7M$520.2M$465.2M$543.4M
Deuda a Largo$280.7M$278.4M$276.5M$274.3M$272.1M$292.8M$290.3M$287.7M00
Pasivos Totales$516.9M$594.4M$653.7M$720.0M$882.7M$911.9M$920.2M$933.5M$590.6M$711.0M
Reservas-$947.9M-$1.04B-$1.19B-$1.38B-$1.49B-$1.54B-$1.70B-$1.34B-$976.5M-$734.8M
Patrimonio Neto$1.21B$1.20B$1.17B$1.09B$1.07B$1.11B$1.04B$1.20B$1.46B$1.82B
Deuda Total$283.7M$281.4M$279.3M$290.9M$410.2M$416.2M$379.4M$372.2M$75.5M$70.0M
Deuda Neta-$335.5M-$309.3M-$260.0M-$244.0M-$224.9M-$120.1M-$229.0M-$401.3M-$676.1M-$1.25B
Capital Circulante$700.6M$674.9M$643.5M$570.9M$672.7M$590.9M$632.6M$965.3M$950.2M$1.39B

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$616.4M$1.12B$351.6M$511.5M
Activos Totales$2.33B$2.53B$4.26B$4.39B
Pasivos Totales$596.1M$711.0M$2.51B$2.58B
Patrimonio Neto$1.73B$1.82B$1.75B$1.81B
Deuda Total$71.6M$70.0M$1.58B$1.57B

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$208.4M-$157.9M-$139.3M-$196.6M-$110.9M-$48.2M-$158.3M$355.8M$367.1M$241.7M
Amortizaciones$94.3M$98.5M$103.7M$80.4M$81.9M$78.7M$77.9M$74.9M$28.5M$27.2M
Compensación en Acciones$94.4M$83.9M$105.4M$101.0M$90.2M$87.6M$94.3M$100.9M$96.6M$98.7M
Cambio en Capital Circulante-$27.2M-$4.9M-$7.4M$65.4M$13.1M-$25.5M$12.7M-$36.7M-$98.2M$119.1M
Flujo de Caja Operativo-$63.8M$19.2M$99.3M$72.1M$82.8M$101.7M$21.0M$401.4M$439.1M$520.8M
Inversiones (CapEx)-$43.7M-$51.3M-$69.4M-$90.9M-$42.2M-$29.0M-$38.3M-$48.0M-$33.5M-$40.4M
Adquisiciones-$15.0M$162000$507000-$8.0M$2.8M-$713000$4850000$98.0M$2.8M
Recompra de Acciones-$13.5M-$16.4M-$19.6M-$9.3M-$7.7M-$16.6M-$18.2M-$28.5M-$200.3M-$31.0M
Dividendos Pagados0000000000
Flujo de Caja Libre-$107.5M-$32.1M$29.9M-$18.9M$40.6M$72.7M-$17.2M$353.3M$405.6M$480.3M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$101.7M$170.1M-$165.7M$145.2M
Inversiones (CapEx)-$17.3M$20000-$4.1M-$8.1M
Flujo de Caja Libre$84.4M$170.1M-$169.8M$137.0M
Dividendos Pagados0000
Compensación en Acciones$24.7M-$72.4M0$31.1M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+21.1%+21.1%+7.0%-11.3%+13.0%-5.3%+49.6%-6.4%-5.2%
Crecimiento Beneficio Neto (anual)+24.2%+11.8%-41.1%+43.6%+56.6%-228.6%+324.8%+3.2%-34.2%
Crecimiento BPA (anual)+25.4%+12.6%-38.9%+44.0%+57.1%-223.3%+320.6%+3.7%-33.8%
Cambio en Acciones (anual)+1.3%+1.1%+1.3%+1.1%+1.3%+1.7%+3.7%-0.3%-0.3%
Crecimiento FCF (anual)+70.1%+193.0%-163.2%+315.3%+79.0%-123.7%+2152.8%+14.8%+18.4%
Margen Bruto82.3%82.9%83.9%84.6%82.8%83.2%80.4%84.8%84.2%86.7%
Margen Operativo-28.0%-16.4%-9.1%-15.0%-10.8%8.3%-0.5%24.9%27.0%17.2%
Margen EBITDA-14.1%-3.6%-0.7%-8.8%-0.6%15.1%5.4%31.2%31.8%22.4%
Margen Neto-28.0%-17.5%-12.7%-16.8%-10.7%-4.1%-14.2%21.4%23.6%16.4%
Margen FCF-14.4%-3.6%2.7%-1.6%3.9%6.2%-1.5%21.2%26.0%32.5%
Tasa Impositiva Efectiva2.8%-10.2%-9.7%0.2%-14.8%12.9%-6.5%-23.2%16.1%17.1%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.71$-0.21$0.19$-0.12$0.26$0.45$-0.11$2.08$2.40$2.85
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$151.5M$153.4M$155.1M$157.1M$158.8M$160.9M$163.7M$166.2M$165.4M$164.7M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Margen bruto84.56%
Margen operativo7.03%
Margen neto3.97%

Salud financiera

Deuda / Patrimonio0.87
Ratio corriente2.30

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-40.28-53.14-32.79-16.32-28.50-77.53-26.9412.9612.9519.03
P/VC6.966.983.912.952.973.364.103.833.252.53
P/V11.299.294.182.743.053.193.852.773.053.12
Margen Bruto82.3%82.9%83.9%84.6%82.8%83.2%80.4%84.8%84.2%86.7%
Margen Operativo-28.0%-16.4%-9.1%-15.0%-10.8%8.3%-0.5%24.9%27.0%17.2%
Margen Neto-28.0%-17.5%-12.7%-16.8%-10.7%-4.1%-14.2%21.4%23.6%16.4%

Empresas relacionadas: ACAD · ACLX · AKRO · ARWR · CRSP · KYMR · PCVX

Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic

Más secciones de ALKS: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones